Quetiapine therapy for posttraumatic stress disorder

Annals of Pharmacotherapy

Volumn 36, Issue 12, 2002, Pages 1875-1878

  Sattar, S Pirzada ^a,b   Ucci, Bernadette ^c   Grant, Kathleen ^b   Bhatia, Subhash C ^a,b   Petty, Frederick ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Posttraumatic stress disorder; PTSD; Quetiapine

Indexed keywords

ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; BUSPIRONE; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; TRAZODONE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ALCOHOLISM; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; EXPERIENCE; FAMILY HISTORY; GROUP THERAPY; HAMILTON SCALE; HUMAN; MALE; NIGHTMARE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SIDE EFFECT; MIDDLE AGED;

ALCOHOLISM; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; HUMANS; MALE; MIDDLE AGED; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0036894754     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C040     Document Type: Article

References (20)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington, DC: American Psychiatric Association. 1994:424-9.
2. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
3. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a clinician-administered PTSD scale. J Trauma Stress 1995;8:75-90.
4. Kohn R. Beta-blockers an important cause of depression: A medical myth without evidence. Med Health R 12001;84:92-5.
5. Duffy JD, Malloy PF. Efficacy of buspirone in the treatment of posttraumatic stress disorder: An open trial. Ann Clin Psychiatry 1994;6:33-7.
6. Hamner M, Ulmer H, Horne D. Buspirone potentiation of antidepressants in the treatment of PTSD. Depress Anxiety 1997;5:137-9.
7. Pecknold JC. A risk-benefit assessment of buspirone in the treatment of anxiety disorders. Drug Saf 1997;16:118-32.
8. Petty F, Brannan S, Casada J, Davis LL, Gajewski V, Kramer GL, et al. Olanzapine treatment for post-traumatic stress disorder: An open-label study. Int Clin Psychopharmacol 2001;16:331-7.
9. Butterfield MI, Becker ME, Connor KM, Sutherland S, Churchill LE, Davidson JR. Olanzapine in the treatment of post-traumatic stress disorder: A pilot study. Int Clin Psychopharmacol 2001;16:197-203.
10. Krashin D, Oates EW. Risperidone as an adjunct therapy for post-traumatic stress disorder. Mil Med 1999;164:605-6.
11. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-60.
12. Hankin CS, Spiro A, Miller DR, Kazis L. Mental disorders and mental health treatment among US Department of Veterans Affairs outpatients: The Veterans Health Study. Am J Psychiatry 1999;156:1924-30.
13. Marshall RD, Cloitre M. Maximizing treatment outcome in post-traumatic stress disorder by combining psychotherapy with pharmacotherapy. Curr Psychiatry Rep 2000;2:335-40.
14. Davidson JR, Nemeroff CB. Pharmacotherapy in posttraumatic stress disorder: Historical and clinical considerations and future directions. Psychopharmacol Bull 1989;25:422-5.
15. Kosten TR, Fontana A, Sernyak MJ, Rosenheck R. Benzodiazepine use in posttraumatic stress disorder among veterans with substance abuse. J Nerv Ment Dis 2000;188:454-9.
16. El-Khayat R, Baldwin DS. Antipsychotic drugs for non-psychotic patients: Assessment of the benefit/risk ratio in generalized anxiety disorder. J Psychopharmacol 1998;12:323-9.
17. Eidelman I, Seedat S, Stein DJ. Risperidone in the treatment of acute stress disorder in physically traumatized in-patients. Depress Anxiety 2000;11:187-8.
18. 2 receptor occupancy. Arch Gen Psychiatry 2000;57:553-9.
19. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311-20.
20. Wong YW, Yeh C, Thyrum PT. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine. J Clin Psychopharmacol 2001;21:89-93.